Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”

Saved in:

Bibliographic Details
Main Authors:	Stefano Bibbò, Maria Pina Dore, Giovanni Cammarota
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2018/7328057
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
by: Hessam Yaghmaei, et al.
Published: (2024-01-01)

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
by: Jinsheng Yu, et al.
Published: (2016-01-01)

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
by: Carmine Carbone, et al.
Published: (2019-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
by: Elena Paschetta, et al.
Published: (2015-01-01)

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
by: Roberto Martínez-Beamonte, et al.
Published: (2020-01-01)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
by: Ga Eun Nam, et al.
Published: (2018-01-01)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
by: Stefano Bibbò, et al.
Published: (2014-01-01)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
by: Abdelfattah El Ouaamari, et al.
Published: (2013-01-01)

Nonalcoholic Fatty Liver Disease in Patients Investigated for Elevated Liver Enzymes
by: Krikor Kichian, et al.
Published: (2003-01-01)

Can Gut Microbiota Analysis Reveal <i>Clostridioides difficile</i> Infection? Evidence from an Italian Cohort at Disease Onset
by: Roberto Rosato, et al.
Published: (2024-12-01)

Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD)
by: Vanja Kalacun, et al.
Published: (2025-12-01)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
by: Camelia Cojocariu, et al.
Published: (2020-01-01)

Nonalcoholic Fatty Liver Disease: A Clinical Approach and Review
by: Maitreyi Raman, et al.
Published: (2006-01-01)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
by: Anna Alisi, et al.
Published: (2011-01-01)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Elena Buzzetti, et al.
Published: (2015-01-01)

The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
by: Said A Al-Busafi, et al.
Published: (2012-01-01)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
by: Hongjie Ou, et al.
Published: (2019-01-01)

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
by: Wenxia Lu, et al.
Published: (2016-01-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
by: Anna Virginia Adriana Pirozzi, et al.
Published: (2020-01-01)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
by: Ana-Maria Singeap, et al.
Published: (2021-01-01)

Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats
by: Şule Demir, et al.
Published: (2016-01-01)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
by: Caihua Wang, et al.
Published: (2019-01-01)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
by: Rajalingham Sakthiswary, et al.
Published: (2014-01-01)

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease
by: Bai Li, et al.
Published: (2022-01-01)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
by: Ivana Mikolasevic, et al.
Published: (2020-01-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis
by: Stefania Bruno, et al.
Published: (2019-01-01)

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
by: Yi-Sun Song, et al.
Published: (2013-01-01)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01)

Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids
by: Jindong Zhao, et al.
Published: (2025-02-01)

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Seon Young Ahn, et al.
Published: (2020-01-01)

RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease
by: Kamyar Asadipooya, et al.
Published: (2019-01-01)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
by: Hwa Young Ahn, et al.
Published: (2018-01-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

Increasing Whole Grain Intake as Part of Prevention and Treatment of Nonalcoholic Fatty Liver Disease
by: Alastair B. Ross, et al.
Published: (2013-01-01)

Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
by: Julia Uhanova, et al.
Published: (2016-01-01)

Understanding the Role of Exercise in Nonalcoholic Fatty Liver Disease: ERS-Linked Molecular Pathways
by: Yong Zou, et al.
Published: (2020-01-01)